BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 28624413)

  • 1. Intronic miR-6741-3p targets the oncogene SRSF3: Implications for oral squamous cell carcinoma pathogenesis.
    More DA; Singh N; Mishra R; Muralidharan HP; Gopinath KS; Gopal C; Kumar A
    PLoS One; 2024; 19(5):e0296565. PubMed ID: 38781195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. circSMARCA5 Is an Upstream Regulator of the Expression of miR-126-3p, miR-515-5p, and Their mRNA Targets,
    Merulla AE; Stella M; Barbagallo C; Battaglia R; Caponnetto A; Broggi G; Altieri R; Certo F; Caltabiano R; Ragusa M; Barbagallo GMV; Di Pietro C; Purrello M; Barbagallo D
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the expression of oncogene SRSF3 by blocking an exonic splicing suppressor with antisense oligonucleotides.
    Guo J; Che X; Wang X; Jia R
    RSC Adv; 2018 Feb; 8(13):7159-7163. PubMed ID: 35540349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological function and molecular mechanism of SRSF3 in cancer and beyond.
    Xiong J; Chen Y; Wang W; Sun J
    Oncol Lett; 2022 Jan; 23(1):21. PubMed ID: 34858525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Non-coding RNA Rhabdomyosarcoma 2-Associated Transcript Regulates Angiogenesis in Endothelial Cells.
    Alaqeeli M; Mayaki D; Hussain SNA
    Front Physiol; 2021; 12():729157. PubMed ID: 34744768
    [No Abstract]   [Full Text] [Related]  

  • 6. Emerging Roles of SRSF3 as a Therapeutic Target for Cancer.
    Zhou Z; Gong Q; Lin Z; Wang Y; Li M; Wang L; Ding H; Li P
    Front Oncol; 2020; 10():577636. PubMed ID: 33072610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of AJUBA, YAP1, and MMP14 expression in esophageal squamous cell carcinoma.
    Zhang Q; Lou L; Cai X; Hao Z; Nie S; Liu Y; Su L; Wu W; Shen H; Li Y
    Int J Clin Exp Pathol; 2018; 11(12):6018-6024. PubMed ID: 31949690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-212-3p inhibits the Proliferation and Invasion of Human Hepatocellular Carcinoma Cells by Suppressing CTGF expression.
    Chen JQ; Ou YL; Huang ZP; Hong YG; Tao YP; Wang ZG; Ni JS; Hao LQ; Lin H
    Sci Rep; 2019 Jul; 9(1):9820. PubMed ID: 31285444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-132-3p represses Smad5 in MC3T3-E1 osteoblastic cells under cyclic tensile stress.
    Liu M; Sun F; Feng Y; Sun X; Li J; Fan Q; Liu M
    Mol Cell Biochem; 2019 Aug; 458(1-2):143-157. PubMed ID: 31004309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-Induced MicroRNA-212/132 Alter Blood-Brain Barrier Integrity Through Inhibition of Tight Junction-Associated Proteins in Human and Mouse Brain Microvascular Endothelial Cells.
    Burek M; König A; Lang M; Fiedler J; Oerter S; Roewer N; Bohnert M; Thal SC; Blecharz-Lang KG; Woitzik J; Thum T; Förster CY
    Transl Stroke Res; 2019 Dec; 10(6):672-683. PubMed ID: 30617994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of microRNA-132 and its target gene NAG-1 in evaluating therapeutic efficacy of non-steroidal anti-inflammatory drugs treatment in patients with ankylosing spondylitis.
    Guo TM; Yan Y; Cao WN; Liu Q; Zhu HY; Yang L; Gao MC; Xing YL
    Clin Rheumatol; 2018 May; 37(5):1281-1293. PubMed ID: 29497899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SRSF3-regulated miR-132/212 controls cell migration and invasion by targeting YAP1.
    Kim HR; Hwang SJ; Shin CH; Choi KH; Ohn T; Kim HH
    Exp Cell Res; 2017 Sep; 358(2):161-170. PubMed ID: 28624413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-1908-5p contributes to the oncogenic function of the splicing factor SRSF3.
    Kim HR; Shin CH; Lee H; Choi KH; Nam DH; Ohn T; Kim HH
    Oncotarget; 2017 Jan; 8(5):8342-8355. PubMed ID: 28039456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-1285-3p is a potential prognostic marker in human osteosarcoma and functions as a tumor suppressor by targeting YAP1.
    Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
    Cancer Biomark; 2019; 25(1):1-10. PubMed ID: 31006663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA NOC2L-4.1 functions as a tumor oncogene in cervical cancer progression by regulating the miR-630/YAP1 pathway.
    Wang Q; Ding J; Nan G; Lyu Y; Ni G
    J Cell Biochem; 2019 Oct; 120(10):16913-16920. PubMed ID: 31099044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic SRSF3 in health and diseases.
    Jia R; Zheng ZM
    Int J Biol Sci; 2023; 19(10):3057-3076. PubMed ID: 37416784
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.